Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > MD&A

<< Previous

Bullboard Posts

Next >>

Comment by waynedon Feb 28, 2012 6:59pm

237 Views

Post# 19601310

RE: MD&A

It`s hardly the first time this has happened . In the past few years there have been several times when I`ve found important info at sedar that is never released . I just don`t understand these guys . They have a great company yet they refuse to promote it . As I have said before , they take out nice wages for themselves so there is little incentive to push the company . They got a huge wad of cash last year by selling our gold mine for 3 plus million . Somehow they have already gone through a million and change of that . As always it does no good to try and contact them . I love the blurb in the corporate governance where they say they will address shareholder concerns at any time . Ha!

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages